|
1) Shimasaki S, Zachow RJ, Li D, et al. A functional bone morphorogenetic protein system in the ovary. Proc Natl Acad Sci U S A. 1999; 96: 7282- 7
|
|
|
|
2) Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein gene. Am J Hum Genet. 2004; 75: 106-11
|
|
|
|
|
|
3) Laissue P, Christin-Maitre S, Touraine P, et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol. 2006; 154: 739-44
|
|
|
|
|
|
4) Groome NP, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 1996; 81: 1401-5
|
|
|
|
|
|
5) Dong J, Albertini DF, Nishimori K, et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996; 383: 531-5
|
|
|
|
|
|
6) Dube JL, Wang P, Elvin J, et al. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol. 1998; 12: 1809-17
|
|
|
|
|
|
7) Shimasaki S, Moore RK, Otsuka F, et al. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev. 2004; 25: 72- 101
|
|
|
|
|
|
8) Liao WX, Moore RK, Shimasaki S. Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9. J Biol Chem. 2004; 23: 17391-6
|
|
|
|
|
|
9) Hashimoto O, Moore RK, Shimasaki S. Posttranslational processing of mouse and human BMP-15: potential implication in the determination of ovulation quota. Proc Natl Acad Sci U S A. 2005; 102: 5426-31
|
|
|
|
|
|
10) Aaltonen J, Laitinen MP, Vuojolainen K, et al. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab. 1999; 84: 2744-50
|
|
|
|
|
|
11) Miyazawa K, Shinozaki M, Hara T, et al. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells. 2002; 7: 1191-204
|
|
|
|
|
|
12) Lawson KA, Dunn NR, Roelen BA, et al. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Development. 1999; 13: 424-36
|
|
|
|
|
|
13) Ying Y, Liu XM, Marble A, et al. Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol Endocrinol. 2000; 14: 1053-63
|
|
|
|
|
|
14) Ying Y, Zhao GQ. Cooperation of endoderm-derived BMP2 and extraembryonic ectoderm-derived BMP4 in primordial germ cell generation in the mouse. Dev Biol. 2001; 232: 484-92
|
|
|
|
|
|
15) de Sousa Lopes SM, Roelen BA, Monteiro RM, et al. BMP signaling mediated by ALK2 in the visceral endoderm is necessary for the generation of primordial germ cells in the mouse embryo. Genes & Development. 2004; 18: 1838-49
|
|
|
|
|
|
16) Chang H, Matzuk MM. Smad5 is required for mouse primordial germ cell development. Mech Dev. 2001; 104: 61-7
|
|
|
|
|
|
17) Tremblay KD, Dunn NR, Robertson EJ. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development. 2001; 128: 3609-21
|
|
|
|
|
|
18) Miyoshi T, Otsuka F, Suzuki J, et al. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells. Biol Reprod. 2006; 74: 1073-82
|
|
|
|
|
|
19) Lee WS, Yoon SJ, Yoon TK, et al. Effects of bone morphogenetic protein-7 (BMP-7) on primordial follicular growth in the mouse ovary. Mol Reprod Dev. 2004; 69: 159-63
|
|
|
|
|
|
20) Yan C, Wang P, DeMayo J, et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 2001; 15: 854-66
|
|
|
|
|
|
21) Yoshino O, McMahon HE, Sharma S, et al. A unique preovulatory expression pattern plays a key role in the physiological functions of BMP-15 in the mouse. Proc Natl Acad Sci U S A. 2006; 103: 10678-83
|
|
|
|
|
|
22) Gilchrist RB, Ritter LJ, Myllymaa S, et al. Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation. J Cell Sci. 2006; 119: 3811-21
|
|
|
|
|
|
23) Galloway SM, McNatty KP, Cambridge LM, et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet. 2000; 5: 279-83
|
|
|
|
|
|
24) Palmer JS, Zhao ZZ, Hoekstra C, et al. Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab. 2006; 91: 4713-6
|
|
|
|
|
|
25) Otsuka F, Yao Z, Lee T, et al. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem. 2000; 275: 39523-8
|
|
|
|
|
|
26) Hussein TS, Froiland DA, Amato F, et al. Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins. J Cell Sci. 2005; 118: 5257-68
|
|
|
|
|
|
27) Orisaka M, Orisaka S, Jiang JY, et al. Growth differentiation factor 9 is antiapoptotic during follicular development from preantral to early antral stage. Mol Endocrinol. 2006; 20: 2456-68
|
|
|
|
|
|
28) Wu X, Chen L, Brown CA, et al. Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice. Mol Endocrinol. 2004; 18: 1509-19
|
|
|
|
|